This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Akpogheneta, O. J.
Right arrow Articles by Conway, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Akpogheneta, O. J.
Right arrow Articles by Conway, D. J.

 Previous Article  |  Next Article 

Infection and Immunity, April 2008, p. 1748-1755, Vol. 76, No. 4
0019-9567/08/$08.00+0     doi:10.1128/IAI.01333-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Duration of Naturally Acquired Antibody Responses to Blood-Stage Plasmodium falciparum Is Age Dependent and Antigen Specific{triangledown} ,{dagger}

Onome J. Akpogheneta,1,2,{ddagger} Nancy O. Duah,1,2 Kevin K. A. Tetteh,2 Samuel Dunyo,1 David E. Lanar,3 Margaret Pinder,1 and David J. Conway1,2*

Medical Research Council Laboratories, Fajara, The Gambia,1 Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel St., London WC1E 7HT, United Kingdom,2 Department of Immunology, Walter Reed Army Institute of Research, Silver Spring, Maryland 209103

Received 4 October 2007/ Returned for modification 19 November 2007/ Accepted 14 January 2008

Naturally acquired antibody responses provide partial protection from clinical malaria, and blood-stage parasite vaccines under development aim to prime such responses. To investigate the determinants of antibody response longevity, immunoglobulin G (IgG) antibodies to several blood-stage vaccine candidate antigens in the sera of two cohorts of children of up to 6 years of age during the dry seasons of 2003 and 2004 in The Gambia were examined. The first cohort showed that most antibodies were lost within less than 4 months of the first sampling if a persistent infection was not present, so the study of the second-year cohort involved collecting samples from individuals every 2 weeks over a 3-month period. Antibody responses in the second cohort were also influenced by persistent malaria infection, so analysis focused particularly on children in whom parasites were not detected after the first time point. Antibodies to most antigens declined more slowly in children in the oldest age group (>5 years old) and more rapidly in children in the youngest group (<3 years old). However, antibodies to merozoite surface protein 2 were shorter lived than antibodies to other antigens and were not more persistent in older children. The age-specific and antigen-specific differences were not explained by different IgG subclass response profiles, indicating the probable importance of differential longevities of plasma cell populations rather than antibody molecules. It is likely that young children mostly have short-lived plasma cells and thus experience rapid declines in antibody levels but that older children have longer-lasting antibody responses that depend on long-lived plasma cells.

* Corresponding author. Mailing address: Medical Research Council Laboratories, Fajara, P.O. Box 273, Banjul, The Gambia. Phone: 220 449 5917. Fax: 220 449 6513. E-mail: dconway{at}mrc.gm

{triangledown} Published ahead of print on 22 January 2008.

{dagger} Supplemental material for this article may be found at http://iai.asm.org/.

Editor: W. A. Petri, Jr.

{ddagger} Present address: The Population Council, Rockefeller University, 1230 York Ave., New York, NY 10028.

Infection and Immunity, April 2008, p. 1748-1755, Vol. 76, No. 4
0019-9567/08/$08.00+0     doi:10.1128/IAI.01333-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Takala, S. L., Coulibaly, D., Thera, M. A., Batchelor, A. H., Cummings, M. P., Escalante, A. A., Ouattara, A., Traore, K., Niangaly, A., Djimde, A. A., Doumbo, O. K., Plowe, C. V. (2009). Extreme Polymorphism in a Vaccine Antigen and Risk of Clinical Malaria: Implications for Vaccine Development. Sci Transl Med 1: 2ra5-2ra5 [Abstract] [Full Text]  
  • Bejon, P., Warimwe, G., Mackintosh, C. L., Mackinnon, M. J., Kinyanjui, S. M., Musyoki, J. N., Bull, P. C., Marsh, K. (2009). Analysis of Immunity to Febrile Malaria in Children That Distinguishes Immunity from Lack of Exposure. Infect. Immun. 77: 1917-1923 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»